Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Potential predictors of quality of life in Parkinson's Disease: Sleep and mood disorders.

Palmeri R, Lo Buono V, Bonanno L, Sorbera C, Cimino V, Bramanti P, Di Lorenzo G, Marino S.

J Clin Neurosci. 2019 Aug 14. pii: S0967-5868(19)31129-4. doi: 10.1016/j.jocn.2019.08.058. [Epub ahead of print]

PMID:
31421992
2.

Leadless pacemaker implantation: A feasible and reasonable option in transcatheter heart valve replacement patients.

Moore SKL, Chau KH, Chaudhary S, Rubin G, Bayne J, Avula UMR, Wang DY, Sorbera C, Dizon J, Biviano A, Waase M, Iyer V, George I, Kodali SK, Nazif TM, Garan H, Wan EY.

Pacing Clin Electrophysiol. 2019 May;42(5):542-547. doi: 10.1111/pace.13648. Epub 2019 Mar 18.

PMID:
30829416
3.

Sleep disturbances are mainly improved by deep brain stimulation of the subthalamic nucleus.

Ricciardi L, Sorbera C, Barbuto M, Morgante F.

Mov Disord. 2019 Jan;34(1):154-155. doi: 10.1002/mds.27588. No abstract available.

PMID:
30653735
4.

What About the Role of Virtual Reality in Parkinson Disease's Cognitive Rehabilitation? Preliminary Findings From a Randomized Clinical Trial.

Maggio MG, De Cola MC, Latella D, Maresca G, Finocchiaro C, La Rosa G, Cimino V, Sorbera C, Bramanti P, De Luca R, CalabrĂ² RS.

J Geriatr Psychiatry Neurol. 2018 Nov;31(6):312-318. doi: 10.1177/0891988718807973. Epub 2018 Oct 25.

PMID:
30360679
5.

Effects of a sensory-motor orthotic on postural instability rehabilitation in Parkinson's disease: a pilot study.

Volpe D, Pelosin E, Bakdounes L, Masiero S, Bertagnoni G, Sorbera C, Giantin MG.

J Clin Mov Disord. 2017 Jul 6;4:11. doi: 10.1186/s40734-017-0058-y. eCollection 2017.

6.

Acting without being in control: Exploring volition in Parkinson's disease with impulsive compulsive behaviours.

Ricciardi L, Haggard P, de Boer L, Sorbera C, Stenner MP, Morgante F, Edwards MJ.

Parkinsonism Relat Disord. 2017 Jul;40:51-57. doi: 10.1016/j.parkreldis.2017.04.011. Epub 2017 Apr 20.

PMID:
28478995
7.

Speech and gait in Parkinson's disease: When rhythm matters.

Ricciardi L, Ebreo M, Graziosi A, Barbuto M, Sorbera C, Morgante L, Morgante F.

Parkinsonism Relat Disord. 2016 Nov;32:42-47. doi: 10.1016/j.parkreldis.2016.08.013. Epub 2016 Aug 15.

PMID:
27545684
8.

Impulsive-compulsive behaviors in parkin-associated Parkinson disease.

Morgante F, Fasano A, Ginevrino M, Petrucci S, Ricciardi L, Bove F, Criscuolo C, Moccia M, De Rosa A, Sorbera C, Bentivoglio AR, Barone P, De Michele G, Pellecchia MT, Valente EM.

Neurology. 2016 Oct 4;87(14):1436-1441. Epub 2016 Sep 2.

9.

Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up.

Gandhi K, Aronow WS, Desai H, Amin H, Lai HM, Frishman WH, Cohen M, Sorbera C.

Arch Med Sci. 2010 Dec;6(6):900-3. doi: 10.5114/aoms.2010.19299. Epub 2010 Dec 29.

10.

Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure.

Desai H, Aronow WS, Ahn C, Gandhi K, Hussain S, Lai HM, Sharma M, Frishman WH, Cohen M, Sorbera C.

Am J Cardiol. 2010 May 1;105(9):1336-8. doi: 10.1016/j.amjcard.2009.12.057. Epub 2010 Mar 11.

PMID:
20403488
11.

Major adverse cardiac events in patients with moderate to severe renal insufficiency treated with first-generation drug-eluting stents.

Sukhija R, Aronow WS, Palaniswamy C, Singh T, Sukhija R, Kalapatapu K, Mohan D, Pucillo AL, Sorbera C, Kakar P, Weiss MB, Lal P, Monsen CE.

Am J Cardiol. 2010 Feb 1;105(3):293-6. doi: 10.1016/j.amjcard.2009.09.031. Epub 2009 Dec 22.

PMID:
20102937
12.

Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure treated with combined cardiac resynchronization plus implantable cardioverter-defibrillator therapy versus implantable cardioverter-defibrillator therapy.

Desai H, Aronow WS, Ahn C, Tsai FS, Lai HM, Gandhi K, Amin H, Frishman WH, Kalapatapu K, Cohen M, Sorbera C.

J Cardiovasc Pharmacol Ther. 2010 Mar;15(1):37-40. doi: 10.1177/1074248409351408. Epub 2009 Dec 4.

PMID:
19966176
13.

Major adverse cardiac events at long-term follow-up in patients treated with single versus multiple stents during single-vessel percutaneous coronary intervention.

Sukhija R, Aronow WS, Palaniswamy C, Singh T, Ahn C, Kalapatapu K, Chaturvedi B, Pucillo AL, Sorbera C, Kakar P, Weiss MB, Mehta V, Monsen CE.

J Interv Cardiol. 2009 Oct;22(5):427-30. doi: 10.1111/j.1540-8183.2009.00487.x. Epub 2009 Jul 13.

PMID:
19627434
14.

Prevalence of appropriate cardioverter-defibrillator shocks in 1038 consecutive patients with implantable cardioverter-defibrillators.

Kruger A, Aronow WS, Lai H, Desai H, Singla A, Frishman WH, Cohen M, Sorbera C.

Am J Ther. 2009 Jul-Aug;16(4):323-5. doi: 10.1097/MJT.0b013e3181727a59.

PMID:
19617719
15.

Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.

Desai H, Aronow WS, Tsai FS, Ahn C, Lai HM, Amin H, Gandhi K, Frishman WH, Cohen M, Sorbera C.

J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):176-9. doi: 10.1177/1074248409340157. Epub 2009 Jul 17.

PMID:
19617418
16.
17.

Prevalence of complications during implantation and during 38-month follow-up of 1060 consecutive patients with implantable cardioverter-defibrillators.

Tsai FS, Aronow WS, Devabhaktuni S, Desai H, Kruger A, Lai HM, Frishman WH, Cohen M, Sorbera C.

Am J Ther. 2010 Jan-Feb;17(1):e8-10. doi: 10.1097/MJT.0b013e3181855c6b.

PMID:
19262366
18.

Effect of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins on mortality in patients with implantable cardioverter-defibrillators.

Lai HM, Aronow WS, Kruger A, Desai H, Amin H, Frishman WH, Cohen M, Sorbera C.

Am J Cardiol. 2008 Jul 1;102(1):77-8. doi: 10.1016/j.amjcard.2008.02.103. Epub 2008 Apr 22.

PMID:
18572039
22.

Indications for and long-term survival in patients with automatic implantable cardioverter-defibrillators.

Aronow WS, Sorbera C, Chagarlamudi A, Tabandeh H, Gupta S, Cohen M.

Cardiol Rev. 2005 Jan-Feb;13(1):50-1.

PMID:
15596030
23.

Simultaneous use of bilateral subthalamic nucleus stimulators and an implantable cardiac defibrillator. Case report.

Rosenow JM, Tarkin H, Zias E, Sorbera C, Mogilner A.

J Neurosurg. 2003 Jul;99(1):167-9.

PMID:
12854761
24.

Indications for implantable cardioverter defibrillator therapy.

Sorbera CA, Cusack EJ.

Heart Dis. 2002 May-Jun;4(3):166-70. Review.

PMID:
12028602
25.

Pediatric radiofrequency ablation for tachyarrhythmias: the Westchester Medical Center experience.

Woolf PK, Sorbera C, Cohen M.

Heart Dis. 2000 Sep-Oct;2(5):336-9.

PMID:
11728278
26.

Radiofrequency catheter ablation: the first decade.

Sorbera C, Cohen M, Christiana J.

Heart Dis. 1999 Sep-Oct;1(4):210-20.

PMID:
11720627
27.

Sudden cardiac death and coronary spasm: a case report.

Sorbera C, Hadid A, Cohen M.

Heart Dis. 1999 Jul-Aug;1(3):136-7.

PMID:
11720616
28.

Syncope and preexcitation: a case of a Kent and fasciculoventricular Mahaim fibers.

Sorbera C, Cohen M, Woolf P.

Heart Dis. 1999 May-Jun;1(2):63-5.

PMID:
11720606
30.

Atrioventricular nodal reentry tachycardia: slow pathway ablation using the transseptal approach.

Sorbera C, Cohen M, Woolf P, Kalapatapu SR.

Pacing Clin Electrophysiol. 2000 Sep;23(9):1343-9.

PMID:
11025889
31.

The effect of ibutilide on retrograde accessory pathway conduction.

Sorbera C, Cohen M.

Pacing Clin Electrophysiol. 2000 Feb;23(2):220-3.

PMID:
10709230
32.

Symptomatic atrioventricular dual pathway double responses: a role for slow pathway ablation.

Sorbera C, Cohen M, Dhakam S, Fazio J.

Pacing Clin Electrophysiol. 1999 Jun;22(6 Pt 1):958-61.

PMID:
10392397
33.

Safety and efficacy of outpatient transseptal radiofrequency ablation of atrioventricular accessory pathways.

Sorbera C, Dhakam S, Cohen M, Woolf P, Agarwal Y.

J Interv Card Electrophysiol. 1999 Jul;3(2):173-5.

PMID:
10387133
34.

Heart rate variability and the outcome of head-up tilt in syncopal children.

Stewart JM, Erb M, Sorbera C.

Pediatr Res. 1996 Nov;40(5):702-9.

PMID:
8910935
35.

Reversible late potentials due to ischemia.

Rubin DA, Sorbera C, Cook J, McAllister A, Burke RM, Weiss MB.

Pacing Clin Electrophysiol. 1992 Dec;15(12):2250-4.

PMID:
1282246
36.

Prospective evaluation of heart block complicating early Lyme disease.

Rubin DA, Sorbera C, Nikitin P, McAllister A, Wormser GP, Nadelman RB.

Pacing Clin Electrophysiol. 1992 Mar;15(3):252-5.

PMID:
1372717
37.

Subacute pulmonary toxicity from amiodarone.

Rubin DA, McAllister A, Sorbera C, Kay RH.

N Y State J Med. 1991 Sep;91(9):403-5. No abstract available.

PMID:
1945154
38.

Acute reversible diffuse conduction system disease due to Lyme disease.

Rubin DA, Sorbera C, Baum S, McAllister A, Nadelman R.

Pacing Clin Electrophysiol. 1990 Nov;13(11 Pt 1):1367-70.

PMID:
1701888

Supplemental Content

Loading ...
Support Center